Silver Book Fact

Aspirin use in AFib patients

Meta-analysis of a number of randomized controlled trials found that aspirin use in atrial fibrillation patients
reduced stroke risk by an average 22%.

Hart R, Benavente O, McBride R, Pearce L. Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation. Ann Intern Med. 1999; 131(7): 492-501. http://www.annals.org/content/131/7/492.1.full

Reference

Title
Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Publication
Ann Intern Med
Publication Date
1999
Authors
Hart R, Benavente O, McBride R, Pearce L
Volume & Issue
Volume 131, Issue 7
Pages
492-501
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Effects of optimal anticoagulation among AFib patients
    If 50% of individuals with atrial fibrillation who do not receive prophylaxis were optimally anti-coagulated, 19,380 emboli would be prevented and $1.1 billion would be saved each year.  
  • Stroke rates among Afib patients
    In one year, 58,283 of the 1.265 million Medicare beneficiaries with atrial fibrillation that did not receive prophylaxis suffered a stroke. For those who did receive anti-coagulants, 38,468 suffered strokes.  
  • Per-patient annual cost of treating stroke in atrial fibrillation patients
    The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…  
  • Cost-savings associated with optimal anticoagulation in AFib patients
    If half of all atrial fibrillation patients receiving suboptimal or no anticoagulation instead received optimal anticoagulation, 28,000 strokes could be prevented each year at a savings of around $2.5 billion in direct…  
  • Effectiveness of pacemaker/defibrillators to control AFib
    Widespread use of pacemaker/defibrillators to control atrial fibrillation could result in a 50% decrease in stroke.